Svenska Cellulosa Ab Sca Class A · OMXSTO:SCA_A
Svenska Cellulosa Ab Sca Class A — Svenska Cellulosa Aktiebolaget SCA — FY2011 Earnings Presentation
21 slides from Svenska Cellulosa Ab Sca Class A's earnings presentation, 2012
Slide 1: Year-end report 2011
Year-end report 2011 1 January – 31 December 2011 Year-end report 2011
Slide 2: Key events
Key events Binding offer to acquire Georgia-Pacific’s European tissue operations Divesting the Packaging business, excluding the two kraftliner mills Acquisitions in emerging markets Established joint venture in Australasia Efficiency program New hygiene organization Wind power joint v
Slide 3: Summary: Full year 2011 vs Full year 2010
Summary Full year 2011 vs Full year 2010 Sales increased 4%* Hygiene business Higher volumes and prices Good growth in emerging markets • Personal care, 13%** • Tissue, 10%** Packaging Packaging volumes flat*** Corrugated prices increased 9% Forest Products Publication paper volume
Slide 4: Summary: Q4 2011 vs Q4 2010
Summary Q4 2011 vs Q4 2010 Sales increased 1%* Hygiene business Higher volumes in Personal Care and flat volumes in Tissue Higher prices Good growth in emerging markets • Personal care, 16%** • Tissue, 10%** Packaging Packaging volumes decreased 3%*** Corrugated prices increased 6%
Slide 5: Items affecting comparability
Items affecting comparability Full year 2011 vs Full year 2010 Items affecting comparability amounted to SEK 5,676m (931) Write-down of assets in the packaging operations: SEK 3,949m Write-down in connection with the divestment of 50% of the hygiene operations in Australasia: SEK 654m Transa
Slide 6: Full year 2011 results
Full year 2011 results SEK millions Change, Change, unless otherwise stated 2011 2010 % %** Net sales 105,750 106,965 -1 4*** EBIT* 9,224 9,608 -4 0 EBIT margin* (%) 8.7 9.0 Profit before tax* 7,934 8,492 -7 -3 Earnings per share (SEK) 0.78 7.90 Cash flow from current operations 6,383 7,399 Debt/Equ
Slide 7: Q4 2011 results
Q4 2011 results SEK millions Q4 Q4 Change, Change, Q3 unless otherwise stated 2011 2010 Q4/Q4,% Q4/Q4,%** 2011 Net sales 26,749 27,052 -1 1*** 26,937 EBIT* 2,527 2,567 -2 1 2,435 EBIT margin* (%) 9.4 9.5 9.0 Profit before tax* 2,167 2,274 -5 -2 2,084 Earnings per share (SEK) -4.88 2.38 1.82 Cash flo
Slide 8: Q4 2011 vs. Q3 2011
Q4 2011 vs. Q3 2011 Summary Group Sales flat EBIT increased 4%* Profit before tax increased 4%* Business areas Personal Care, EBIT increased 15%* • Improved price/mix • Higher volumes • Lower raw material costs Tissue, EBIT increased 29%* • Higher prices and volumes • Lower raw materia
Slide 9: Personal Care
Personal Care Q4 2011 vs. Q4 2010 6,529 6,375 6,310 Sales increased 2% (4%*) Incontinence care increased 5%* 2% Baby diapers increased 5%* Feminine care increased 1%* Emerging markets increased 16%* SALES SEKm Q411 Q410 Q311 EBIT increased by 8%** (12%***) Higher volumes 792** 735 Hi
Slide 10: Tissue
Tissue Q4 2011 vs. Q4 2010 10,280 10,154 9,951 Sales increased 1% (3%*) 1% Consumer tissue flat* AFH tissue increased 6%* Emerging markets increased 10%* SALES SEKm Q411 Q410 Q311 EBIT increased 33%** (37%***) Higher prices Improved product mix 1,046** 787 809** Lower raw material co
Slide 11: Packaging
Packaging Q4 2011 vs. Q4 2010 Sales decreased 6% (flat*) Higher prices 6,704 6,810 Lower volumes 6,287 -6% EBIT decreased 25%** (23%***) Higher prices Cost savings SALES SEKm Q411 Q410 Q311 Higher raw material costs Lower volumes 567 534** Negative currency impact 428** -25%** EBIT
Slide 12: Forest Products
Forest Products Q4 2011 vs. Q4 2010 Sales decreased 3% 4,155 4,290 4,349 Lower volumes -3% Higher publication paper prices EBIT decreased 26%* Higher raw material costs SALES SEKm Q411 Q410 Q311 Negative currency impact Higher prices 592 534* 440* -26%* EBIT SEKm Q411 Q410 Q311 EBIT ma
Slide 13: Dividend
Dividend Proposed 5% increase of the dividend to SEK 4.20 (4.00) per share 13 Year-end report 2011
Slide 14: Binding offer for Georgia-Pacific's European tissue operations
Binding offer for Georgia-Pacific’s European tissue operations Creates a leading European tissue company Strengthens our product offering and geographic reach Offered price: EUR 1.32bn Sales: EUR 1.25bn Annual synergies: EUR 125m With fully realized synergies earnings per share are expec
Slide 15: Divestment of Packaging
Divestment of Packaging Supports SCA’s strategy Divestment of Packaging to DS Smith Enables increased growth in the hygiene business SCA’s two kraftliner mills in Sweden are not included Purchase price: EUR 1.7bn on a debt free basis Earnings per share decrease by SEK 0.73* The hygiene b
Slide 16: Strategic focus areas
Strategic focus areas 16 Year-end report 2011
Slide 17: Efficiency
Efficiency Restructuring program in baby diapers in Europe finalized Efficiency program Mainly related to Personal Care and Tissue Annual cost savings: SEK 700m Gradual impact during 2012-2013 Annualized savings in Q4 2011: SEK 200m New hygiene organization Investments in new capacit
Slide 18: Innovation
Innovation Strengthens market positions and profitability 18 Year-end report 2011
Slide 19: Growth
Growth Binding offer for Georgia-Pacific´s European tissue operations High growth in emerging markets Acquisition in Brazil Pro Descart, No. 2 in incontinence care products Acquisitions in Turkey San Saglik 95%, No. 2 in incontinence care products Komili 50%, No. 4 in baby diapers and
Slide 20: Q&A Year-end report 2011
Q&A 20 Year-end report 2011
Slide 21: IR Contacts
IR Contacts: Johan Karlsson, VP Investor Relations Jessica Ölvestad, Manager Investor Relations Tel: +46 8 788 51 30 Tel: +46 8 788 52 82 Email: ir@sca.com Website: www.sca.com 21 Year-end report 2011
Svenska Cellulosa Aktiebolaget SCA — FY2011 Earnings Presentation on 6ix